Same strategy for pitfalls of radiotherapy in different anatomical districts
| Autor: | Serena Zacchigna, Matteo Biasotto, Giulia Ottaviani, Margherita Gobbo, Roberto Di Lenarda, Francesca Ciriello, Katia Rupel, Aulo Beorchia |
|---|---|
| Přispěvatelé: | Gobbo, Margherita, Ottaviani, Giulia, Rupel, Katia, Ciriello, Francesca, Beorchia, Aulo, DI LENARDA, Roberto, Zacchigna, Serena, Biasotto, Matteo |
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Male medicine.medical_specialty Erythema Visual analogue scale Healing Pain Dermatology Enteral administration 03 medical and health sciences 0302 clinical medicine Breast cancer Internal medicine Neoplasms medicine Mucositis Humans Functional ability Prospective Studies Low-Level Light Therapy Prospective cohort study Adverse effect Aged Stomatitis business.industry Oral Mucositis Oral Mucositi Middle Aged medicine.disease Radiodermatiti Surgery 030104 developmental biology Treatment Outcome 030220 oncology & carcinogenesis Laser Therapy Radiodermatitis Quality of Life Female medicine.symptom Lasers Semiconductor business |
| DOI: | 10.1007/s10103-015-1857-8?view=classic |
| Popis: | Oral mucositis (OM) and radiodermatitis (RD) are serious side effects of radiotherapy (RT), often leading to its suspension, need for analgesics, and enteral/parenteral nutrition. Laser therapy is becoming a recommended treatment option. This prospective study aimed at demonstrating the beneficial effect of class IV laser therapy (HPLT) on RT-induced OM, an off-label use of HPLT to treat RD in breast cancer patients. Fifty-three cancer patients, during/after RT and/or chemotherapy (CT), affected by OM, were treated with HPLT during four consecutive days (970 ± 15 nm, 5 W (50 %), 35-6000 Hz, 240 s). Assessment of OM (Grading Objective Scale, WHO-SCALE), pain (visual analogue scale, VAS), functional ability, subjective parameters, and site/severity of OM were recorded over time. Similarly, 27 breast cancer patients affected by RD were treated by HPLT and monitored over time for grade, discomfort, itching, and bleeding. Progressive improvement of WHO-SCALE from day 7 on, and of VAS from day 2 on (p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|